Volume 138, Issue 6 pp. 508-514
ORIGINAL ARTICLE

Hyposmia in a simple smell test is associated with accelerated cognitive decline in early Parkinson's disease

Kristian Varden Gjerde

Corresponding Author

Kristian Varden Gjerde

Division of Psychiatry, Haukeland University Hospital, Bergen, Norway

Department of Clinical Medicine (K1), University of Bergen, Bergen, Norway

Correspondence: Kristian Varden Gjerde, Division of Psychiatry, Haukeland University Hospital, Postal box 1400, 5021 Bergen, Norway ([email protected]; [email protected]).Search for more papers by this author
Bernd Müller

Bernd Müller

Department of Clinical Medicine (K1), University of Bergen, Bergen, Norway

Department of Neurology, Haukeland University Hospital, Bergen, Norway

Search for more papers by this author
Geir Olve Skeie

Geir Olve Skeie

Department of Clinical Medicine (K1), University of Bergen, Bergen, Norway

Department of Neurology, Haukeland University Hospital, Bergen, Norway

Search for more papers by this author
Jörg Assmus

Jörg Assmus

Centre for Clinical Research, Haukeland University Hospital, Bergen, Norway

Search for more papers by this author
Guido Alves

Guido Alves

Department of Neurology, Stavanger University Hospital, Stavanger, Norway

The Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway

Department of Mathematics and Natural Sciences, University of Stavanger, Stavanger, Norway

Search for more papers by this author
Ole-Bjørn Tysnes

Ole-Bjørn Tysnes

Department of Clinical Medicine (K1), University of Bergen, Bergen, Norway

Department of Neurology, Haukeland University Hospital, Bergen, Norway

Search for more papers by this author
First published: 30 July 2018
Citations: 25

Funding information

The Norwegian ParkWest study is partly funded by the Research Council of Norway (grant#177966), the Western Norway Regional Health Authority (grant# 911218) and the Norwegian Parkinson Research Foundation.

Abstract

Objectives

Olfactory dysfunction has been related to cognitive deficits in Parkinson's disease (PD), but evidence is conflicting and little is known about the relationship between these symptoms in early PD. Our objective was to study the association between smell deficits measured with a simple odor identification test at diagnosis of PD and the subsequent risk of cognitive decline.

Materials & methods

One hundred and ninety two PD patients from a population-based study were examined at time of diagnosis, before initiation of dopaminergic treatment, with follow-up of 177 patients after 3 years, 162 patients after 5 years and 146 patients after 7 years. Cognitive function was assessed repeatedly with tests of global cognition, verbal memory, visuospatial abilities, processing speed, and executive function. Olfactory function was tested with a simple odor identification test at baseline. Associations between outcome measures and hyposmia were assessed by linear mixed effects models.

Results

After 7 years, there were significant differences in global cognition (B: 1.96 (95% CI: 0.68, 3.24), P = 0.0031), verbal memory including immediate recall (B: 5.36 (95% CI: 2.04, 8.67), P = 0.0018) and delayed recall (B: 1.55 (95% CI: 0.51, 2.59), P = 0.0041) and word reading speed (B: 6.90 (95% CI: 2.17, 11.63), P = 0.0048) between hyposmic and normosmic PD patients.

Conclusions

The decline of cognitive function in early PD is more rapid in patients with hyposmia at diagnosis, compared to normosmic ones. A simple smell test may contribute to identify patients at risk of accelerated decline in global cognition, verbal memory, and processing speed within the first 7 years from diagnosis.

CONFLICTS OF INTEREST

Kristian Varden Gjerde, Bernd Müller, Geir Olve Skeie, Jörg Assmus, Guido Alves, and Ole-Bjørn Tysnes report no disclosures relevant to the manuscript.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.